Biopharmaceutical companies led to a nearly 18 percent increase in corporate philanthropy in 2010
New drug failure rates rising in Phase II and III clinical trials
China's Fluorine Industry Grows‎
Ex-Pfizer R&D chief questions calls for wholesale pharma outsourcing
Quetiapine Fumarate
111974-72-2

Bortezomib
179324-69-7

Azacosterol
313-05-3

Methyl boronic acid
13061-96-6

5-Nitroisatoic anhydride
4693-02-1

DI-2-PYRIDYL CARBONATE
1659-31-0

Diisopropyl azodicarboxylate
2446-83-5

2-methylpropane-1-sulfonyl chl...
35432-36-1

5-chloro-1,3-dimethyl-1H-pyraz...
27006-82-2